Currently browsing: Activities

The CRM Trial Connect 2024 is on its third consecutive year and was held in collaboration with the European Organization for Research & Treatment of Cancer (EORTC) and the National Cancer Center Japan. The conference was aimed to showcase Malaysia’s accomplishments in sponsored clinical research and promote collaborations between local and international clinical research stakeholders.

We are thrilled about this remarkable achievement at the fifth Business Excellence Award (BEA) 2024, hosted by the British Malaysian Chamber of Commerce (BMCC). AstraZeneca and Clinical Research Malaysia have won the prestigious UK-Malaysia Partnership of the Year Award, encompassing clinical trials, governance meetings, and site visits.

Malaysia reaches new peaks in clinical research! In 2023, Malaysia has achieved 276 studies, securing our spot as Southeast Asia’s #2 for global industry-sponsored research.

Commencing from 1 March 2024, the rate of Service Tax under the Service Tax 2018 is increased from 6% to 8%.

Embark on your journey with our comprehensive 12-week Study Coordinator training program!

Roche Pharmaceuticals, one of the world’s largest pharmaceutical companies has confirmed Sarawak General Hospital as Site for a First-in-Human (FIH) clinical trial in Malaysia.

Clinical Research Malaysia (CRM) and the Pharmaceutical Association of Malaysia (PhAMA) have entered a strategic partnership to propel the development of clinical research talents and skills in Malaysia

Malaysian oncologists garnered attention for their active involvement and co-authorship in studies, with a particular focus on two studies showcasing promising outcomes for new lung cancer treatments. This underscores Malaysia’s increasing influence in global oncology research.

Malaysia made history this month when one of its Medical Oncologist, Dr Voon Pei Jye from Sarawak General Hospital (SGH) became the first Malaysian to be invited to co-author a First-in-Human trial publication.

New Industrial Plan (NIMP) 2030